Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study on Trabectedin in Advanced Rearranged Mesenchymal Chondrosarcoma

NCT04305548 is registered in ClinicalTrials.gov with Italian Sarcoma Group as lead sponsor.

NCT NCT04305548
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04305548 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study on Trabectedin in Advanced Rearranged Mesenchymal Chondrosarcoma
Lead sponsor
Italian Sarcoma Group
Phase
Phase 2
Overall status
Recruiting
Start date
September 14, 2021
Completion date
December 31, 2026
Enrollment
16 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

mesenchymal chondrosarcoma